149 related articles for article (PubMed ID: 33642141)
41. Prognostic assessment of different lymph node staging methods for pancreatic cancer with R0 resection: pN staging, lymph node ratio, log odds of positive lymph nodes.
La Torre M; Nigri G; Petrucciani N; Cavallini M; Aurello P; Cosenza G; Balducci G; Ziparo V; Ramacciato G
Pancreatology; 2014; 14(4):289-94. PubMed ID: 25062879
[TBL] [Abstract][Full Text] [Related]
42. Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma.
Li G; Chen JZ; Chen S; Lin SZ; Pan W; Meng ZW; Cai XR; Chen YL
Cancer Med; 2020 May; 9(10):3353-3370. PubMed ID: 32181599
[TBL] [Abstract][Full Text] [Related]
43. The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer.
Guo S; Shang M; Dong Z; Zhang J; Wang Y; Zhao Y
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e117-e124. PubMed ID: 32762113
[TBL] [Abstract][Full Text] [Related]
44. Modified staging classification of gallbladder carcinoma on the basis of the 8
Wang J; Bo X; Shi X; Suo T; Xin Y; Nan L; Wang C; Ni X; Liu H; Pan H; Shen S; Li M; Lu P; Zhang D; Wang Z; Wang Y; Liu H
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):527-533. PubMed ID: 31630931
[TBL] [Abstract][Full Text] [Related]
45. Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis.
Pu N; Li J; Xu Y; Lee W; Fang Y; Han X; Zhao G; Zhang L; Nuerxiati A; Yin H; Wu W; Lou W
Cancer Manag Res; 2018; 10():227-238. PubMed ID: 29440932
[TBL] [Abstract][Full Text] [Related]
46. Exploration of the lymphadenectomy strategy for elderly pancreatic ductal adenocarcinoma patients undergoing curative-intent resection.
Li Z; Zhang X; Guo C; Sun C; Li Z; Fei H; Chen Y; Zhao D
Am J Cancer Res; 2023; 13(5):1938-1951. PubMed ID: 37293173
[TBL] [Abstract][Full Text] [Related]
47. Site-specific factors for cancer of the corpus uteri from SEER registries: collaborative stage data collection system, version 1 and version 2.
Jamison PM; Altekruse SF; Chang JT; Zahn J; Lee R; Noone AM; Barroilhet L
Cancer; 2014 Dec; 120 Suppl 23():3836-45. PubMed ID: 25412395
[TBL] [Abstract][Full Text] [Related]
48. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma.
Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O
Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859
[TBL] [Abstract][Full Text] [Related]
49. Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database.
Wang J; Dang P; Raut CP; Pandalai PK; Maduekwe UN; Rattner DW; Lauwers GY; Yoon SS
Ann Surg; 2012 Mar; 255(3):478-85. PubMed ID: 22330040
[TBL] [Abstract][Full Text] [Related]
50. Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis.
Hu H; Qu C; Tang B; Liu W; Ma Y; Chen Y; Xie X; Zhuang Y; Gao H; Tian X; Yang Y
Chin J Cancer Res; 2021 Aug; 33(4):457-469. PubMed ID: 34584371
[TBL] [Abstract][Full Text] [Related]
51. Comparison of three lymph node staging schemes for predicting the outcome in patients with small bowel adenocarcinoma: A population-based cohort and international multicentre cohort study.
Zhou YY; Du XJ; Zhang CH; Aparicio T; Zaanan A; Afchain P; Chen LP; Hu SK; Zhang PC; Wu M; Zhang QW; Wang H
EBioMedicine; 2019 Mar; 41():276-285. PubMed ID: 30824384
[TBL] [Abstract][Full Text] [Related]
52. Impact of Lymph Nodes Examined on Survival in ypN0 Gastric Cancer Patients: a Population-Based Study.
MingHua Z; KeCheng Z; ZhenYu C; Lin C; ChunXi W; ZeLong Y
J Gastrointest Surg; 2021 Apr; 25(4):919-925. PubMed ID: 32318943
[TBL] [Abstract][Full Text] [Related]
53. Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP).
Kang JS; Mok L; Heo JS; Han IW; Shin SH; Yoon YS; Han HS; Hwang DW; Lee JH; Lee WJ; Park SJ; Park JS; Kim Y; Lee H; Yu YD; Yang JD; Lee SE; Park IY; Jeong CY; Roh Y; Kim SR; Moon JI; Lee SK; Kim HJ; Lee S; Kim H; Kwon W; Lim CS; Jang JY; Park T
Gut Liver; 2021 Nov; 15(6):912-921. PubMed ID: 33941710
[TBL] [Abstract][Full Text] [Related]
54. Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer.
Schouten TJ; Daamen LA; Dorland G; van Roessel SR; Groot VP; Besselink MG; Bonsing BA; Bosscha K; Brosens LAA; Busch OR; van Dam RM; Fariña Sarasqueta A; Festen S; Groot Koerkamp B; van der Harst E; de Hingh IHJT; Intven M; Kazemier G; de Meijer VE; Nieuwenhuijs VB; Raicu GM; Roos D; Schreinemakers JMJ; Stommel MWJ; van Velthuysen MF; Verdonk RC; Verheij J; Verkooijen HM; van Santvoort HC; Molenaar IQ;
Ann Surg Oncol; 2022 Sep; 29(9):5988-5999. PubMed ID: 35469113
[TBL] [Abstract][Full Text] [Related]
55. A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors.
Gaitanidis A; Patel D; Nilubol N; Tirosh A; Kebebew E
J Clin Endocrinol Metab; 2018 Jan; 103(1):187-195. PubMed ID: 29069375
[TBL] [Abstract][Full Text] [Related]
56. Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma.
Wang H; Lin Z; Li G; Zhang D; Yu D; Lin Q; Wang J; Zhao Y; Pi G; Zhang T
BMC Cancer; 2020 Mar; 20(1):188. PubMed ID: 32138704
[TBL] [Abstract][Full Text] [Related]
57. Application of the Eighth Edition of the American Joint Committee on Cancer Staging for Pancreatic Adenocarcinoma.
Liu C; Cheng H; Jin K; Guo M; Lu Y; Wang Z; Yang C; Long J; Ni Q; Yu X; Luo G
Pancreas; 2018 Jul; 47(6):742-747. PubMed ID: 29851752
[TBL] [Abstract][Full Text] [Related]
58. Examined and positive lymph nodes counts and lymph nodes ratio are associated with survival in major salivary gland cancer.
Elhusseiny KM; Abd-Elhay FA; Kamel MG; Abd El Hamid Hassan HH; El Tanany HHM; Hieu TH; Tieu TM; Low SK; Hou V; Dibas M; Huy NT
Head Neck; 2019 Aug; 41(8):2625-2635. PubMed ID: 30905082
[TBL] [Abstract][Full Text] [Related]
59. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease.
Kulkarni NM; Soloff EV; Tolat PP; Sangster GP; Fleming JB; Brook OR; Wang ZJ; Hecht EM; Zins M; Bhosale PR; Arif-Tiwari H; Mannelli L; Kambadakone AR; Tamm EP
Abdom Radiol (NY); 2020 Mar; 45(3):716-728. PubMed ID: 31748823
[TBL] [Abstract][Full Text] [Related]
60. Stage IA Patients With Pancreatic Ductal Adenocarcinoma Cannot Benefit From Chemotherapy: A Propensity Score Matching Study.
Zhang Y; Xu G; Chen M; Wei Q; Zhou T; Chen Z; Shen M; Wang P
Front Oncol; 2020; 10():1018. PubMed ID: 32766130
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
